Search results
Why BioNTech Was a Sickly Stock This Week
Motley Fool· 1 year agoWhat happened BioNTech (NASDAQ: BNTX), a company that rose to great prominence and a high stock price during the coronavirus pandemic, wasn't much of a...
Moderna, BioNTech Lead Covid Sell-Off After Pfizer Slashes Its Outlook By $9 Billion
Investor's Business Daily· 7 months agoModerna stock and BioNTech led a sell-off Monday among Covid vaccine makers after Pfizer slashed...
BioNTech Pares Losses After Doubling Profits, Raising 2022 Guidance
Investor's Business Daily· 2 years agoBioNTech doubled Wall Street's third-quarter profit expectations Monday and raised its full-year...
Why 'Covid Fatigue' Isn't Enough To Keep BioNTech Down; Shares Surge On Upgrade
Investor's Business Daily· 2 years agoBioNTech snagged an upgrade Wednesday with an analyst saying "Covid fatigue" has obscured its...
The Zacks Analyst Blog Highlights Pfizer, BioNTech, Moderna and Morphic
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – August 25, 2022 – Zacks.com announces the list of stocks...
BioNTech (NASDAQ:BNTX) shareholders have earned a 46% CAGR over the last three years
Simply Wall St. via Yahoo Finance· 1 year agoIt hasn't been the best quarter for BioNTech SE (NASDAQ:BNTX) shareholders, since the share price...
BioNTech (BNTX) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoBioNTech's (BNTX) fourth-quarter COVID-19 vaccine sales are likely to have declined with the...
BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials
Benzinga via Yahoo Finance· 2 months agoBioNTech SE (NASDAQ: BNTX) is way past its glorious Covid-19 days, when it thrived with Pfizer Inc...
Undervalued Biotech Stocks Shine: Pfizer and BioNTech Show Robust Resilience
GuruFocus.com via Yahoo Finance· 8 months agoIn the ever-evolving world of the stock market, uncovering potential gold mines is paramount for...
With New COVID-19 Boosters in Tow, Which Is the Better Buy: Pfizer, BioNtech, or Moderna Stock?
Motley Fool· 8 months agoThe Food and Drug Administration (FDA) just approved the updated Omicron-adapted COVID-19 booster...